Susan S. Jick, DSc
Professor
Boston University School of Public Health
Dept of Epidemiology

MPH, Boston University
DSc, Boston University



Dr. Susan Jick has been in the field of pharmacoepidemiology for over 25 years working with the Boston Collaborative Drug Surveillance Program where she has conducted research in many areas of drug safety. She has been involved with the use and development of large automated databases including the General Practice Research Database which has become a major resource for conducting drug safety studies and has changed the way these studies are being conducted today. Her research activities range from the safety of drugs such as oral contraceptives in relation to venous thrombosis, hormone replacement therapy in relation to cancers, antibiotics in relation to various serious health outcomes, and statins in relation to autoimmune diseases and diabetes, to safety of drug use in the first trimester of pregnancy and use of folic acid to prevent neural tube defects. Dr Jick helps to run a workshop on methods in conducting drug safety studies that is held each year, she teaches the drug epidemiology class at BUSPH and she serves as an advisor to doctoral students in epidemiology.


A Postmarketing Surveillance Study of Otezla
11/01/2015 - 12/29/2017 (PI)
Celgene Corporation

Iodinated contrast agents and risk of hypothyroidism in young children in the United States
04/29/2016 - 10/31/2017 (PI)
Bayer AG

Maternal depression and antidepressant use during pregnancy and risk of childhood autism spectrum disorders in offspring
09/01/2015 - 08/31/2017 (PI)
NIH/National Institute of Child Health & Human Development
5R01HD084680-02

Study of patients with rare disease
05/27/2016 - 05/26/2017 (PI)
EpiSource, LLC Genzyme Corporation

Longitudinal Study of Morbidity and Mortality in Primary Vasculitis
03/01/2015 - 02/28/2017 (PI)
Vasculitis Foundation

Prevalence of hypercalcemia of malignancy (HCM) among cancer patients (C14-018)
02/14/2014 - 12/31/2016 (PI)
Amgen, Inc.

Persistent Side-Effects of 5-Alpha-Reductase Inhibitor Treatment
09/01/2014 - 07/31/2016 (PI)
New England Research Institutes NIH NIDDK
R21DK100820

Incidence, prevalence and treatment patterns of pediatric pulmonary hypertension in the US
09/21/2015 - 03/31/2016 (PI)
Bayer AG

A study to estimate the prevalence of diabetic nephropathy in a pediatric United States population
12/19/2014 - 06/30/2015 (PI)
Bayer AG

Epidemiology of Giant Cell Tumor of the Bone in the UK - Phase II (C13-135)
12/01/2013 - 04/30/2015 (PI)
Amgen, Inc.

Showing 10 of 14 results. Show All Results


Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Hagberg KW, Divan HA, Nickel JC, Jick SS. Risk of Incident Antidepressant-Treated Depression Associated with Use of 5a-Reductase Inhibitors Compared with Use of a-Blockers in Men with Benign Prostatic Hyperplasia: A Population-Based Study Using the Clinical Practice Research Datalink. Pharmacotherapy. 2017 May; 37(5):517-527. PMID: 28295443; DOI: 10.1002/phar.1925;.
  2. Becker C, Jick SS, Meier CR, Bodmer M. Metformin and the risk of renal cell carcinoma: a case-control analysis. Eur J Cancer Prev. 2017 May; 26(3):257-262. PMID: 26945286; DOI: 10.1097/CEJ.0000000000000246;.
  3. Meier CR, Jick SS. Antenatal Exposure and Diseases in the Offspring: The Role of Big Data. Drug Saf. 2017 May; 40(5):363-364. PMID: 28185070; DOI: 10.1007/s40264-017-0514-5;.
  4. Frey N, Jossi J, Bodmer M, Bircher A, Jick SS, Meier CR, Spoendlin J. The Epidemiology of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in the UK. J Invest Dermatol. 2017 Jun; 137(6):1240-1247. PMID: 28202399; DOI: 10.1016/j.jid.2017.01.031;.
  5. Hagberg KW, Divan HA, Fang SC, Nickel JC, Jick SS. Risk of gynecomastia and breast cancer associated with the use of 5-alpha reductase inhibitors for benign prostatic hyperplasia. Clin Epidemiol. 2017; 9:83-91. PMID: 28228662; DOI: 10.2147/CLEP.S124674;.
  6. Frey N, Hügle T, Jick SS, Meier CR, Spoendlin J. Hyperlipidaemia and incident osteoarthritis of the hand: a population-based case-control study. Osteoarthritis Cartilage. 2017 Feb 09. PMID: 28189828; DOI: 10.1016/j.joca.2017.01.014;.
  7. Li L, Neogi T, Jick S. Giant cell arteritis and vascular disease-risk factors and outcomes: a cohort study using UK Clinical Practice Research Datalink. Rheumatology (Oxford). 2017 Jan 11.View Related Profiles. PMID: 28077689; DOI: 10.1093/rheumatology/kew482;.
  8. Seliger C, Meier CR, Becker C, Jick SS, Proescholdt M, Bogdahn U, Hau P, Leitzmann MF. Metabolic syndrome in relation to risk of meningioma. Oncotarget. 2017 Jan 10; 8(2):2284-2292. PMID: 27903988; DOI: 10.18632/oncotarget.13667;.
  9. Spoendlin J, Layton JB, Mundkur M, Meier C, Jick SS, Meier CR. The Risk of Achilles or Biceps Tendon Rupture in New Statin Users: A Propensity Score-Matched Sequential Cohort Study. Drug Saf. 2016 Dec; 39(12):1229-1237. PMID: 27677637.
  10. Seliger C, Meier CR, Becker C, Jick SS, Bogdahn U, Hau P, Leitzmann MF. Reply to Greenland: A serious misinterpretation of a consistent inverse association of statin use with glioma across 3 case-control studies. Eur J Epidemiol. 2017 Jan; 32(1):89-90. PMID: 27896538; DOI: 10.1007/s10654-016-0212-0;.
Showing 10 of 253 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 253 publications over 32 distinct years, with a maximum of 27 publications in 2016

YearPublications
19841
19862
19872
19881
19896
19906
19912
19925
19936
19953
19962
19974
19984
19995
20007
20012
20022
20035
20047
20054
20068
20079
200812
200914
201011
20118
201212
201325
201422
201521
201627
20178
Contact for Mentoring:


11 Muzzey St
Lexington MA 02421
Google Map


Jick's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department